Related posts
Weekly 52-Week Low (or 52-Week High): AC-T, EMA-T, BTE-T, LIO-X and More 52-Week Highs and Lows (Dec 04-10)Most Anticipated Earnings: SLF-T, REAL-T and more Canadian Companies Reporting Earnings this Week (Nov 13-17)Meta sinks marketsThis summary was created by AI, based on 2 opinions in the last 12 months.
The experts have differing opinions on Extendicare Inc's performance and future prospects. The first expert believes that the stock has had a good year but may not have much more potential for capital gains at the current levels, unless there's a substantial pullback. The second expert compares EXE with CSH, highlighting the differences in their operations and financial strategies. They see potential in CSH due to the growing seniors' population and debt reduction, although they also suggest that the easy money may have already been made.
EXE operates long-term care facilities which require a lot of capital, while CSH is more senior homes. CSH has been divesting lower-return investments to become more of a pure-play. You can charge whatever rent in a market if there's no competition. The seniors' population keeps growing. CSH is paying down debt, which was high a few years ago. In CSH, the easy money has been made, though. It could be a keeper, or take profits.
How COVID will effect this industry, retirement homes? He owns Sienna instead. EXE is much more involved in government-funded LTCs. Along with Chartwell, these two companies are under government scrutiny, so they likely do a much better job than private LTCs. Good question how COVID will affect these homes: there may be increased costs to manage the LTCs, and he expects the government to do more oversight, particularly the incompetent LTCs. He prefers Sienna to EXE, because Sienna is a mix of LTCs and retirement homes, while Chartwell is mostly retirement homes, which has more upside but more competitive. Don't buy purely LTCs, like EXE.
Extendicare has a better chart than Chartwell. It has a head-and-shoulder chart movement. If you take into account the general market sell-off, investors need to be forgiving.
Extendicare Inc is a Canadian stock, trading under the symbol EXE-T on the Toronto Stock Exchange (EXE-CT). It is usually referred to as TSX:EXE or EXE-T
In the last year, 2 stock analysts published opinions about EXE-T. 0 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Extendicare Inc.
Extendicare Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Extendicare Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Extendicare Inc In the last year. It is a trending stock that is worth watching.
On 2024-12-13, Extendicare Inc (EXE-T) stock closed at a price of $10.06.
This has been an extremely good performance year for long-term-care REITs. Not sure there's much more in terms of capital gains from where we are now. Unless substantial pullback, wouldn't buy now.